Literature DB >> 28004146

Residual tumor resection (RTR).

A Lusch1, P Albers2.   

Abstract

Residual tumor resection in patients with advanced testicular tumor plays a vital role in the multimodal treatment. Treatment indications for residual tumor resection have changed over the last two decades. While patients with advanced seminoma after chemotherapy or radiotherapy rarely need surgery, it is mandatory for most non-seminomatous tumor patients to undergo post-chemotherapy tumor resection. Due to adjunctive surgical procedures, the operation is surgically demanding and should be performed only in specialized high-volume referral centers. Additional surgical procedures such as nephrectomy, partial colectomy or vascular interventions including caval and aortic resection with grafting might be required. Consequently, several complications can be seen in the peri- and postoperative course. We aim to describe indications for residual tumor resection, operative technique, including adjunctive surgeries and the most common peri- and postoperative complications.

Entities:  

Keywords:  Additional surgical procedures; Residual tumor resection (RTR); Testicular cancer

Mesh:

Year:  2016        PMID: 28004146     DOI: 10.1007/s00345-016-1984-2

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  18 in total

1.  Management of disseminated nonseminomatous germ cell tumors with risk-based chemotherapy followed by response-guided postchemotherapy surgery.

Authors:  Christian Kollmannsberger; Siamak Daneshmand; Alan So; Kim N Chi; Nevin Murray; Christie Moore; Brandon Hayes-Lattin; Craig Nichols
Journal:  J Clin Oncol       Date:  2009-12-21       Impact factor: 44.544

2.  Long-term follow-up of Cisplatin combination chemotherapy in patients with disseminated nonseminomatous germ cell tumors: is a postchemotherapy retroperitoneal lymph node dissection needed after complete remission?

Authors:  Yaron Ehrlich; Mary J Brames; Stephen D W Beck; Richard S Foster; Lawrence H Einhorn
Journal:  J Clin Oncol       Date:  2009-12-21       Impact factor: 44.544

3.  Clinical and pathological features predictive of nephrectomy at post-chemotherapy retroperitoneal lymph node dissection.

Authors:  K Clint Cary; Stephen D W Beck; Richard Bihrle; Richard S Foster
Journal:  J Urol       Date:  2012-09-24       Impact factor: 7.450

4.  Repeat retroperitoneal lymphadenectomy in advanced testicular cancer.

Authors:  Axel Heidenreich; Carsten Ohlmann; Axel Hegele; Jörg Beyer
Journal:  Eur Urol       Date:  2005-01       Impact factor: 20.096

5.  Retroperitoneal lymph node dissection for residual masses after chemotherapy in nonseminomatous germ cell testicular tumor.

Authors:  Murilo A Luz; Ahmed F Kotb; Saad Aldousari; Fadi Brimo; Simon Tanguay; Wassim Kassouf; Armen G Aprikian
Journal:  World J Surg Oncol       Date:  2010-11-09       Impact factor: 2.754

6.  Contemporary trends in postchemotherapy retroperitoneal lymph node dissection: Additional procedures and perioperative complications.

Authors:  Clint Cary; Timothy A Masterson; Richard Bihrle; Richard S Foster
Journal:  Urol Oncol       Date:  2015-01-05       Impact factor: 3.498

7.  Improved clinical outcome in recent years for men with metastatic nonseminomatous germ cell tumors.

Authors:  Brett S Carver; Angel M Serio; Dean Bajorin; Robert J Motzer; Jason Stasi; George J Bosl; Andrew J Vickers; Joel Sheinfeld
Journal:  J Clin Oncol       Date:  2007-11-12       Impact factor: 44.544

Review 8.  Surgery in metastatic testicular cancer.

Authors:  Peter Albers; Diethild Melchior; Stefan C Müller
Journal:  Eur Urol       Date:  2003-08       Impact factor: 20.096

9.  Complications of post-chemotherapy retroperitoneal lymph node dissection.

Authors:  J Baniel; R S Foster; R G Rowland; R Bihrle; J P Donohue
Journal:  J Urol       Date:  1995-03       Impact factor: 7.450

10.  Innovations in health care and mortality trends from five cancers in seven European countries between 1970 and 2005.

Authors:  Rasmus Hoffmann; Iris Plug; Martin McKee; Bernadette Khoshaba; Ragnar Westerling; Caspar Looman; Gregoire Rey; Eric Jougla; Katrin Lang; Kersti Pärna; Johan P Mackenbach
Journal:  Int J Public Health       Date:  2013-08-29       Impact factor: 3.380

View more
  4 in total

1.  Preoperative clinical and radiographic predictors of major vascular surgery in patients with testicular cancer undergoing post-chemotherapy residual tumor resection (PC-RPLND).

Authors:  Alessandro Nini; Matthias Boschheidgen; Andreas Hiester; Christian Winter; Gerald Antoch; Lars Schimmöller; Peter Albers
Journal:  World J Urol       Date:  2021-11-03       Impact factor: 4.226

2.  Preservation of Ejaculatory Function After Postchemotherapy Retroperitoneal Lymph Node Dissection (PC-RPLND) in Patients With Testicular Cancer: Template vs. Bilateral Resection.

Authors:  Andreas Hiester; Alessandro Nini; Anna Fingerhut; Robert Große Siemer; Christian Winter; Peter Albers; Achim Lusch
Journal:  Front Surg       Date:  2019-01-17

Review 3.  Major complications of post-chemotherapy retroperitoneal lymph node dissection in a contemporary cohort of patients with testicular cancer and a review of the literature.

Authors:  Christian Guido Ruf; Simon Krampe; Cord Matthies; Petra Anheuser; Tim Nestler; Jörg Simon; Hendrik Isbarn; Klaus Peter Dieckmann
Journal:  World J Surg Oncol       Date:  2020-09-24       Impact factor: 2.754

4.  Additional surgical procedures and perioperative morbidity in post-chemotherapy retroperitoneal lymph node dissection for metastatic testicular cancer in two intermediate volume hospitals.

Authors:  Joost M Blok; Richard P Meijer; Henk G van der Poel; Axel Bex; Jeanette van Vooren; Japke J van Urk; Simon Horenblas; J L H Ruud Bosch
Journal:  World J Urol       Date:  2020-05-05       Impact factor: 4.226

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.